Lixte Biotechnology (LIXT) had the highest return between August 1, 2014 and August 31, 2014 by a US stock, returning 145%.
| ASSET | DATE | % RETURN |
|---|---|---|
Lixte Biotechnology (LIXT) | 8/1/2014 - 8/31/2014 | 145% |
Data Storage (DTST) | 8/1/2014 - 8/31/2014 | 133.77% |
Kustom Entertainment (KUST) | 8/1/2014 - 8/31/2014 | 110.97% |
Bimergen Energy (BESS) | 8/1/2014 - 8/31/2014 | 109.38% |
Cardiff Oncology (CRDF) | 8/1/2014 - 8/31/2014 | 87.18% |
Edesa Biotech (EDSA) | 8/1/2014 - 8/31/2014 | 78.65% |
Altimmune (ALT) | 8/1/2014 - 8/31/2014 | 74.81% |
Genasys (GNSS) | 8/1/2014 - 8/31/2014 | 74.21% |
Amicus Therapeutics (FOLD) | 8/1/2014 - 8/31/2014 | 71.6% |
Intrusion (INTZ) | 8/1/2014 - 8/31/2014 | 69.18% |
InnovAge (INNV) | 8/1/2014 - 8/31/2014 | 65% |
Arbutus Biopharma (ABUS) | 8/1/2014 - 8/31/2014 | 62.12% |
Prairie Operating Co Common Stock (PROP) | 8/1/2014 - 8/31/2014 | 61.69% |
Optex Systems Holdings, Inc Common Stock (OPXS) | 8/1/2014 - 8/31/2014 | 60% |
NexGen Energy (NXE) | 8/1/2014 - 8/31/2014 | 59.93% |
Coda Octopus (CODA) | 8/1/2014 - 8/31/2014 | 57.65% |
BG Staffing (BGSF) | 8/1/2014 - 8/31/2014 | 56.92% |
Identiv (INVE) | 8/1/2014 - 8/31/2014 | 56.07% |
Digital Turbine (APPS) | 8/1/2014 - 8/31/2014 | 53.95% |
Assertio Therapeutics (ASRT) | 8/1/2014 - 8/31/2014 | 53.65% |
Natural Health Trend (NHTC) | 8/1/2014 - 8/31/2014 | 49.59% |
Theriva Biologics (TOVX) | 8/1/2014 - 8/31/2014 | 48.86% |
MGP Ingredients (MGPI) | 8/1/2014 - 8/31/2014 | 48.63% |
Cadiz (CDZI) | 8/1/2014 - 8/31/2014 | 47.71% |
VerifyMe (VRME) | 8/1/2014 - 8/31/2014 | 47.37% |
